Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/25/2025

Pharmacologic Treatment for Postpartum Anemia

Screening and Risk Assessment

  • The Centers for Disease Control and Prevention recommends screening women at 4-6 weeks postpartum if they have risk factors including anemia persisting through the third trimester, excessive blood loss at delivery (>300 mL), or multiple birth 1, 2
  • The American College of Obstetricians and Gynecologists uses hemoglobin <12 g/dL or hematocrit <36% as diagnostic thresholds for postpartum anemia in non-pregnant women 1
  • Confirm positive screening with repeat hemoglobin or hematocrit before initiating treatment, as recommended by the Centers for Disease Control and Prevention 1, 2

First-Line Oral Iron Therapy

  • The American College of Obstetricians and Gynecologists recommends prescribing 60-120 mg of elemental iron daily as oral ferrous sulfate for treatment of postpartum anemia 1, 2
  • Provide dietary counseling on iron-rich foods (meat, poultry, fortified cereals) and factors that enhance absorption, as suggested by the Centers for Disease Control and Prevention 1, 2
  • Warn patients about expected gastrointestinal side effects including darkening of stool, constipation, and gastrointestinal discomfort, which are generally self-limited, according to the American College of Physicians 3

Monitoring Response to Oral Iron

  • Reassess hemoglobin or hematocrit after 4 weeks of treatment, as recommended by the Centers for Disease Control and Prevention 1, 2
  • The expected response is an increase of ≥1 g/dL in hemoglobin or ≥3% in hematocrit, according to the American College of Obstetricians and Gynecologists 1, 2
  • If no response after 4 weeks despite confirmed compliance and absence of acute illness, perform additional testing including mean corpuscular volume, red cell distribution width, and serum ferritin, as suggested by the Centers for Disease Control and Prevention 1, 2

Intravenous Iron Therapy Indications

  • The American College of Obstetricians and Gynecologists recommends switching to intravenous iron therapy when oral iron fails after 4 weeks despite compliance, when patients cannot tolerate oral iron due to gastrointestinal side effects, or when rapid iron repletion is needed 2, 4
  • Ferric carboxymaltose is the preferred intravenous option due to rapid effectiveness and better tolerability, according to the American College of Physicians 4

Special Populations

  • Vegetarian women may require nearly double the iron supplementation (up to 240 mg daily) due to lower absorption of non-heme iron from plant sources, as recommended by the American College of Obstetricians and Gynecologists 2, 5

Common Pitfalls to Avoid

  • The Centers for Disease Control and Prevention recommends not stopping iron supplementation at delivery if risk factors for postpartum anemia are present 1, 2
  • Do not assume oral iron failure without first confirming medication compliance and ruling out concurrent inflammatory conditions that may blunt response, as suggested by the American College of Physicians 1, 4

Multidisciplinary Collaboration Points

  • Refer to hematology if hemoglobin <9 g/dL or hematocrit <27% for further evaluation, as recommended by the Centers for Disease Control and Prevention 1
  • Consider gastroenterology consultation if occult bleeding or malabsorption is suspected as underlying cause, according to the American College of Gastroenterology 4

REFERENCES